News & Updates

Overeating or binge eating symptoms are linked to lower quality of life, higher prevalence of depression and anxiety, and poor clinical outcomes among adolescents with type 1 diabetes, according to a study.

The glucagon-like peptide-1 receptor agonist (GLP-1 RA) efpeglenatide affords cardiovascular and renal protection that is not explained by concurrent use of a sodium-glucose co-transporter-2 (SGLT2) inhibitor in patients with type 2 diabetes (T2D), according to an exploratory analysis of AMPLITUDE-O.

Remnant cholesterol (C) appears predictive of mortality due to cardiovascular disease (CVD) among patients with type 2 diabetes (T2D), chronic kidney disease (CKD) stage 3 to 5, and incident diabetic nephropathy (DN), suggests a study.

The increase in C-peptide (C-Pep) above fasting following glucose load is associated with response to antihyperglycaemic therapy in patients with new-onset type 2 diabetes mellitus (T2DM), according to a study. The plasma C-Pep concentration ratio (C-Pep120/C-Pep0) may be used for the individualization of such therapy in this population.

A recent study has recognized alanine and glutamine as new amino acids that appear to increase the risk of coronary artery disease (CAD) and reduce the hazard of ischaemic stroke, respectively.

Circulating homocysteine and C677T variant in methylenetetrahydrofolate reductase (MTHFR) appear to influence the prevalence rate and ensuing progression of spinal osteoarthritis (OA), respectively, in postmenopausal women, a study has shown.

Diet quality seems to modify the effect of apolipoprotein B (ApoB) polymorphisms on serum biomarkers in patients with type 2 diabetes mellitus (T2DM), a recent study has found.